About the Program
To improve access to breast and cervical cancer screening, Congress passed the Breast and Cervical Cancer Mortality Prevention Act of 1990,external icon which directed CDC to create the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Currently, the NBCCEDP funds 70 grantees–all 50 states, the District of Columbia, 6 U.S. territories, and 13 American Indian/Alaska Native tribes or tribal organizations.
In 2000, Congress passed the Breast and Cervical Cancer Prevention and Treatment Act,external icon which allowed states to offer women who are diagnosed with cancer in the NBCCEDP access to treatment through Medicaid. In 2001, with passage of the Native American Breast and Cervical Cancer Treatment Technical Amendment Act,external icon Congress explained that his option also applies to American Indians and Alaska Natives who are eligible for health services provided by the Indian Health Service or by a tribal organization.
Through the NBCCEDP, CDC helps low-income, uninsured, and underinsured women gain access to timely breast and cervical cancer screening, diagnostic, and treatment services. NBCCEDP also provides patient navigation services to help women overcome barriers and get timely access to quality care.
In addition to funding screening and diagnostic services for eligible women, the NBCCEDP focuses not only on the behavior choices of individuals, but also on factors that influence those choices at the interpersonal, organizational, community, and policy levels. Therefore, the NBCCEDP supports use of population-based approaches to improve systems that increase high-quality breast and cervical cancer screening. These include–
Since 1991, NBCCEDP-funded programs have–
- Served more than 5.4 million women.
- Provided more than 13.0 million breast and cervical cancer screening examinations.
- Diagnosed 65,879 invasive breast cancers and 21,126 premalignant breast lesions.
- Diagnosed 4,524 invasive cervical cancers and 207,727 premalignant cervical lesions, of which 39% were high-grade.
About 11.1% of U.S. women are eligible for NBCCEDP cervical cancer screening, and about 9.8% are eligible for breast cancer screening. In 2012, the program served 6.5% of eligible women for cervical cancer screening and 10.6% of those eligible for breast cancer screening.
In calendar year 2017, the NBCCEDP—
- Provided breast cancer screening and diagnostic services to 285,504 women and diagnosed 2,521 invasive breast cancers and 765 premalignant breast lesions.
Provided cervical cancer screening and diagnostic services to 138,590 women and diagnosed 168 invasive cervical cancers and 5,990 premalignant cervical lesions, of which 37% were high-grade.